PAR

Par Drugs & Chemicals Share Price

 

 

Start SIP in PAR

Start SIP
Par Drugs & Chemicals live price: ₹86.81. It opened at ₹90 vs previous close ₹89; intraday high/low: ₹90/₹86. The 50 & 200 DMA stand at ₹94.02/₹106.51.

Par Drugs & Chemicals Performance

  • Low
  • ₹86
  • High
  • ₹90
  • 52 Week Low
  • ₹81
  • 52 Week High
  • ₹122
  • Open Price₹90
  • Previous Close₹89
  • Volume8,503
  • 50 DMA₹94.02
  • 100 DMA₹96.39
  • 200 DMA₹106.51

Investment Returns

  • Over 1 Month -10.41%
  • Over 3 Month -14.46%
  • Over 6 Month -17.93%
  • Over 1 Year -11.18%

Smart Investing Starts Here Start SIP with Par Drugs & Chemicals for Steady Growth!

Invest Now

Par Drugs & Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7.7
  • PEG Ratio
  • -0.8
  • Market Cap Cr
  • 107
  • P/B Ratio
  • 1
  • Average True Range
  • 4.3
  • EPS
  • 11.3
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.03
  • RSI
  • 37.29
  • MFI
  • 23.8

Par Drugs & Chemicals Financials

Par Drugs & Chemicals Technicals

EMA & SMA

Current Price
₹86.81
-1.81 (-2.04%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹92.14
  • 50 Day
  • ₹94.02
  • 100 Day
  • ₹96.39
  • 200 Day
  • ₹106.51

Resistance and Support

87.7 Pivot Speed
  • R3 92.79
  • R2 91.39
  • R1 89.10
  • S1 85.41
  • S2 84.01
  • S3 81.72

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Par Drugs and Chemicals has an operating revenue of Rs. 106.37 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 18% is great, ROE of 13% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 27% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Par Drugs & Chemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-10 Quarterly Results & Others To consider other business matters issue in the ratio of 1:1 of Rs. 10/-.
2025-11-13 Quarterly Results & Others To consider other business matters issue in the ratio of 1:1 of Rs. 10/-.
2025-08-29 Others To consider other business matters issue in the ratio of 1:1 of Rs. 10/-.
2025-08-07 Quarterly Results & Others To consider other business matters issue in the ratio of 1:1 of Rs. 10/-.
2025-05-08 Audited Results & Others To consider other business matters issue in the ratio of 1:1 of Rs. 10/-.
Date Purpose Remarks
2021-04-28 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

Par Drugs & Chemicals F&O

Par Drugs & Chemicals Shareholding Pattern

73.41%
0%
20.03%
6.56%

About Par Drugs & Chemicals

  • NSE Symbol
  • PAR
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Falgun Vallabhbhai Savani
  • ISIN
  • INE04LG01015

Similar Stocks to Par Drugs & Chemicals

Par Drugs & Chemicals FAQs

Par Drugs & Chemicals share price is ₹86 As on 16 March, 2026 | 21:55

The Market Cap of Par Drugs & Chemicals is ₹106.8 Cr As on 16 March, 2026 | 21:55

The P/E ratio of Par Drugs & Chemicals is 7.7 As on 16 March, 2026 | 21:55

The PB ratio of Par Drugs & Chemicals is 1 As on 16 March, 2026 | 21:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23